Cortex to Hold Conference Call on October 26 Following Release of CX717 from FDA Clinical Hold Tuesday October 24, 10:10 am ET IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (AMEX:COR - News) received the formal letter from the U.S. Food and Drug Administration on Monday, October 23, 2006 regarding the lifting of the clinical hold on Cortex's lead product candidate, AMPAKINE...


